Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Tunik S et al. | 2013 | animal, rat/Wistar albino, whole body | magnetic field, signals/pulses, 50/60 Hz | 1.5 mT |
Huang CY et al. | 2014 | intact cell/cell culture, HaCaT cells (human keratinocytes) partially transfected with CHK2 siRNA | magnetic field, 50/60 Hz, shielding/field deprivation | 1.5 mT |
Huang CY et al. | 2014 | intact cell/cell culture, human epidermal keratinocytes (derived from neonatal foreskin) and HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1.5 mT |
Ardeshirylajimi A et al. | 2015 | intact cell/cell culture, human induced pluripotent stem cells | magnetic field, signals/pulses, 50/60 Hz | 1.5 mT |
Zhou J et al. | 2021 | intact cell/cell culture, newborn rat calvarial osteoblasts, animal, rat/Wistar | magnetic field, 50/60 Hz, low frequency | 1.8 mT |
Harrison GH et al. | 1997 | intact cell/cell culture, A172 (human glioblastoma cells), MCF7 WT(human breast cancer cell line) and HeLa S3 (human cervical carcinoma cell line) | magnetic field, 50/60 Hz | 2 mT |
Balcer-Kubiczek EK et al. | 1998 | DNA/RNA, intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 2 mT |
Balcer-Kubiczek EK et al. | 2000 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
Schmidt-Rohlfing B et al. | 2008 | intact cell/cell culture, chondrocytes (from human articular cartilage of osteoarthritic knee joints) | magnetic field, low frequency, signals/pulses, 50/60 Hz, electrotherapy | 2 mT |
Hasanzadeh H et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 2 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.